Stocktoria

LIFECORE BIOMEDICAL, INC. \DE\ LFCR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1996-02-15

LIFECORE BIOMEDICAL, INC. \DE\ statistics & valuation

Market cap$193.9M
P / S1.5×
Net margin-30.0%
FCF margin-10.6%
Net debt$122.2M
Enterprise value USD$316.1M
Earnings yield EBIT/EV-5.5%
Return on capital-8.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2.20% 2.00% 4.70% 0.10% -23.90% -32.00% -104.90% -96.40% 9.40% -30.00% 2016201720182019202020212022202320242025
Gross margin (%)
12.30% 14.90% 14.90% 14.50% 24.60% 38.60% 35.10% 27.10% 32.60% 31.30% 2016201720182019202020212022202320242025
Operating margin (%)
-3.80% 2.80% 2.60% 1.00% -16.20% -8.70% -10.60% -21.10% -6.90% -13.40% 2016201720182019202020212022202320242025
Return on equity (%)
-5.50% 4.60% 9.80% 0.20% -16.60% -16.00% -132.90% 106.20% -2898.00% 2016201720182019202020212022202320242025
Shares outstanding
27.1M 27.7M 27.9M 29.1M 29.2M 29.3M 29.5M 30.3M 36.7M 37.0M 2016201720182019202020212022202320242025
Net debt ($)
$43.9M $41.2M $39.4M $95.9M $112.6M $164.1M $97.2M $65.7M $116.2M $122.2M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-3.40% 3.00% 6.10% 0.10% -13.00% -6.40% -42.50% -39.30% 4.70% -16.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-3.30% 1.30% -2.60% -5.10% -18.30% -2.80% -43.90% -14.10% -10.60% 2016201720182019202020212022202320242025
Debt / equity (×)
0.25× 0.21× 0.17× 0.36× 0.49× 0.82× 1.12× 11.02× 97.63× 2016201720182019202020212022202320242025
EPS ($)
-$0.43 $0.38 $0.89 $0.01 -$1.31 -$1.10 -$3.97 -$3.32 $0.33 -$1.27 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

LIFECORE BIOMEDICAL, INC. \DE\ trades at about 14.5× earnings — below its 10-year norm (10-year range 15.5×–937×, median 17.6×).

14.5× 937×

Shaded band = 10-year range (15.5×–937×); dot = today's 14.5×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Gross margin31.3%32.6%27.1%35.1%38.6%24.6%14.5%14.9%14.9%12.3%
Operating margin-13.4%-6.9%-21.1%-10.6%-8.7%-16.2%1.0%2.6%2.8%-3.8%
Net margin-30.0%9.4%-96.4%-104.9%-32.0%-23.9%0.1%4.7%2.0%-2.2%
FCF margin-10.6%-14.1%—-43.9%-2.8%-18.3%-5.1%-2.6%1.3%-3.3%
Return on assets-16.2%4.7%-39.3%-42.5%-6.4%-13.0%0.1%6.1%3.0%-3.4%
Return on equity-2898.0%106.2%2353.7%-132.9%-16.0%-16.6%0.2%9.8%4.6%-5.5%
Debt / equity97.63×11.02×-20.06×1.12×0.82×0.49×0.36×0.17×0.21×0.25×
Current ratio2.842.082.390.661.430.960.971.101.581.53

Computed from company filings · US · as of 2025-05-25. Facts plus Stocktoria's own computed scores — not investment advice.